Xu Tan
- Biomedical Engineering top 2%
- Materials Chemistry top 10%
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Biomaterials top 5%
- Co-authors
- Chunmeng ShiShenglin LuoYongping SuTianmin ChengTao LiuErlong ZhangYu WangDechun Wang
- Topics
- Nanoplatforms for cancer theranostics (20 papers)Photodynamic Therapy Research Studies (7 papers)Cancer Research and Treatments (5 papers)
- Partner nations
- ChinaUnited StatesArgentina
In The Last Decade
Xu Tan
47 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 102
- Biomedical Engineering 1.4k
- Materials Chemistry 618
- Pulmonary and Respiratory Medicine 579
- Molecular Biology 530
- Biomaterials 306
Countries citing papers authored by Xu Tan
This map shows the geographic impact of Xu Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Tan more than expected).
Fields of papers citing papers by Xu Tan
This network shows the impact of papers produced by Xu Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Tan. The network helps show where Xu Tan may publish in the future.
Co-authorship network of co-authors of Xu Tan
This figure shows the co-authorship network connecting the top 25 collaborators of Xu Tan. A scholar is included among the top collaborators of Xu Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu Tan. Xu Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 17 | |
| 2 | 2 | |
| 3 | 2 | |
| 4 | 4 | |
| 5 | 8 | |
| 6 | 6 | |
| 7 | 7 | |
| 8 | 24 | |
| 9 | 16 | |
| 10 | 8 | |
| 11 | 0 | |
| 12 | The human positive cofactor 4 promotes androgen-independent prostate cancer development and progression through HIF-1α/β-catenin pathway. | 6 |
| 13 | 28 | |
| 14 | 28 | |
| 15 | 42 | |
| 16 | 195 | |
| 17 | 16 | |
| 18 | 115 | |
| 19 | 198 | |
| 20 | 86 |
About Xu Tan
Xu Tan is a scholar working on Biophysics, Biotechnology and Biomedical Engineering, having authored 48 papers that have together received 2.0k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (20 papers), Photodynamic Therapy Research Studies (7 papers) and Cancer Research and Treatments (5 papers). The work is most often cited by research in Biomedical Engineering (1.4k citations), Biomaterials (306 citations) and Pulmonary and Respiratory Medicine (579 citations). Xu Tan has collaborated with scholars based in China, United States and Argentina. Frequent co-authors include Chunmeng Shi, Shenglin Luo, Yongping Su, Tianmin Cheng, Tao Liu, Erlong Zhang, Yu Wang, Dechun Wang, Sheng‐Tao Fang and Qingrong Qi. Their work appears in journals such as Advanced Materials, Journal of Clinical Oncology and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.